Hyprosan

Hypromellose, the active ingredient in Hyprosan, is an excipient presented as a unspecified strength/unspecified form for ocular use. It facilitates drug delivery in eye drops and helps maintain ocular surface moisture for patients requiring ophthalmic therapy.

GNH USA supplies Hyprosan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Hyprosan, as a hypromellose‑based ophthalmic excipient, is employed in formulations that address ocular surface conditions. - Dry eye syndrome: provides lubrication and prolongs tear film stability. - Ocular surface lubrication: reduces friction and discomfort during blinking. - Post‑operative ocular care: aids in maintaining corneal hydration after eye surgery. - Contact lens wear: improves comfort by creating a protective film. - Allergic conjunctivitis: serves as a vehicle for anti‑inflammatory agents, enhancing their residence time.

Hypromellose eye preparations are generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Transient blurred vision: temporary visual disturbance after instillation. - Mild eye irritation: sensation of foreign body or burning. - Temporary tearing: increased lacrimation shortly after use. - Conjunctival hyperemia: mild redness of the eye. - Pruritus: itching sensation. - Sensation of stickiness: feeling of residue on the eye.

Serious or Rare Side Effects: - Severe allergic reaction: swelling, rash, or anaphylaxis. - Corneal edema: swelling of the cornea affecting vision. - Persistent ocular inflammation: prolonged redness or pain. - Vision loss: rare but serious impairment of sight. - Intraocular pressure rise: unexpected increase in eye pressure. - Contact lens intolerance: inability to wear lenses after use.

When using Hyprosan, consider the following safety measures. - Allergy assessment: verify no known hypersensitivity to cellulose derivatives. - Contact lens use: remove lenses before instillation and wait several minutes before reinserting. - Ocular infection: avoid use if active bacterial or viral eye infection is present. - Concurrent ophthalmic drugs: separate administration times to prevent dilution. - Pediatric use: consult a specialist before use in children. - Store at ambient temperature: keep in original container, protect from moisture and direct light.

Hypromellose may interact with other ophthalmic products; monitor for compatibility.

Major Interactions (Avoid): - Preservative‑containing drops: may cause precipitation or reduced efficacy. - Anticholinergic eye drops: can alter tear film dynamics leading to discomfort.

Moderate Interactions (Monitor Closely): - Topical antibiotics: spacing required to maintain optimal drug concentration. - Anti‑inflammatory eye drops: may dilute therapeutic effect if administered simultaneously. - Mydriatic agents: possible alteration in pupil response when combined.